Luis Alvarez
Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) have reached a settlement and license agreement with Regeneron Pharmaceuticals (REGN) concerning the launch of AVT06, Alvotech’s proposed biosimilar to Eylea (aflibercept) in the United States.
The settlement grants a license entry date for